Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of LPM3480392 for Postoperative Pain After Abdominal Surgery
NCT06204120Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LPM3480392 in postoperative pain (6 arms), sponsored by Luye Pharma Group. Primary endpoint: Sum of Pain Intensity Differences over 24 Hours. Started Nov 2022; status: completed.
02
Drugs
LPM3480392
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06204120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06204120.